Nektar stands to win big bucks as drug decision nears By: San Francisco Business Times via Business Journals September 15, 2014 at 20:08 PM EDT Nektar Therapeutics Inc. and partner AstraZeneca will discover Tuesday if regulators have approved their treatment for opioid-induced constipation... Read More >> Related Stocks: Pfizer
